Could These 3 Potential Blockbusters Transform Biogen?

Could These 3 Potential Blockbusters Transform Biogen?

Source: 
Motley Fool
snippet: 
  • Newly commercialized Aduhelm and two pipeline candidates could be game changers.
  • The controversial Aduhelm should offer us clues about Biogen’s future over the coming year.
  • Biogen shares are only about $100 away from their record high.